Daniel Levine, principal of the Levine Media Group, and host of Bio Report and RARECast podcasts, interviews Dr.Krishnan Nandabalan on the propagation of data in the life sciences

As biomedical data proliferates and the life sciences become more closely integrated with data science, the ability for researchers to access, use, and learn from the growing universe of information requires new tools. InveniAI is seeking to address this need with its artificial intelligence platform for biopharmaceutical companies to both monitor innovation and to enhance their own drug development capabilities. We spoke to Krishnan Nandabalan, president and CEO of InveniAI, about the company, how its artificial intelligence platform is being used, and what he expects the ultimate payoff from this technology will be.